Sonoma Pharmaceuticals, Inc. - Form 8-K Summary
Business Context and Reporting Period
This Form 8-K, dated June 5, 2017, serves as a current report for Sonoma Pharmaceuticals, Inc. The filing announces the issuance of a press release detailing financial results for the fiscal quarter and fiscal year ended March 31, 2017.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. These metrics are contained within the press release furnished as Exhibit 99.1, which is incorporated by reference but not detailed in the body of this 8-K.
Material Changes
The document does not explicitly list material changes versus prior periods. It directs readers to the attached press release (Exhibit 99.1) for the full results of operations and financial condition.
Guidance, Outlook, and Risks
The filing includes a standard disclaimer regarding forward-looking statements. Management notes that these statements involve risks, uncertainties, and assumptions that could cause actual results to differ materially from expectations. Specific risks are referenced as being discussed in the Company's Annual Report on Form 10-K. The Company states it has no obligation to update forward-looking statements except as required by law.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release) for specific revenue, net income, and cash flow figures for the quarter and year ended March 31, 2017.
- Verify the details of the forward-looking statements and associated risk factors in the most recent Form 10-K.
- Confirm the status of the Company's emerging growth company designation (noted as unchecked in this filing).